Home > PRODUCTS > Focused libraries > Disease-based libraries

Newsletter Subscription

Stay updated with our new products and services. You can unsubscribe at any time.

Disease-based targeted libraries
Diabetes Targeted Libraries

Diabetes Targeted LibrariesHundreds millions of people have diabetes worldwide. Diabetes is estimated to have resulted in 1.5 to 5.0 million deaths each year. Today researchers are making a lot of efforts to develop new, more effective compounds to treat this disease. OTAVAchemicals offers 5 Diabetes Targeted Libraries designed with Ligand-based and Receptor-based approach. These libraries are proposed for screening in diabetes-associated research and drug development projects.

Alzheimer's Disease Targeted Libraries

Alzheimer's disease targeted librariesDuring the past decades, several agents have been approved that enhance cognition of Alzheimer's disease (AD) patients. However, the effectiveness of these treatments are limited or controversial and they do not modify disease progression. Recent advances in understanding AD pathogenesis have led to the development of numerous compounds that might modify the disease process. Taking into account AD complexity, it becomes clear that polypharmacology with drugs targeting different sites could be the future treatment approach and a majority of the recent drugs under evaluation seems to act on multiple targets.